Table 2 Factors associated with the occurrence of ACS

Age

1.08

1.03–1.12

0.001

1.05

1.01–1.10

0.008

Male

3.54

1.45–8.60

0.005

2.26

0.89–5.71

0.085

Smoking

1.92

0.77–4.78

0.162

BMI (continuous variable)

1.11

1.00–1.23

0.049

Hypertension

4.27

0.58–31.44

0.154

-

-

-

DM

3.55

1.78–7.05

<0.001

2.58

0.99–6.76

0.054

Dialysis before KT (vs. preemptive)

1.58

0.46–5.38

0.469

-

-

-

Dialysis vintage (months)

1.01

0.99–1.013

0.146

Cholesterol (<150 mg/dL)

1.46

0.69–3.07

0.324

Intact PTH

1.00

0.99–1.00

0.384

Recipient CMV IgG (+)

0.01

0.01–20.16

0.998

Donor sex (male)

0.64

0.31–1.29

0.208

-

-

-

Donor age

1.03

0.99–1.06

0.094

-

-

-

Deceased donor (vs. living donor)

2.72

1.12–6.61

0.027

2.17

0.80–5.91

0.128

Donor CMV IgG (+)

0.891

0.44–1.79

0.745

CsA (vs. tacrolimus)

1.9

0.91–3.95

0.085

-

-

-

NODAT

2.80

1.24–6.32

0.013

2.88

1.03–8.10

0.045

CMV disease

0.046

0.01–14.33

0.686

0.15

0.01–41.48

0.712

MIA factors

 Albumin (lowest quartile vs. others)

2.04

0.98–4.24

0.056

2.33

1.11–4.88

0.026

 CRP (highest quartile vs. others)

1.89

0.94–3.82

0.075

1.55

0.75–3.20

0.237

 Previous history of vascular disease^a

6.41

3.09–13.33

<0.001

2.61

1.08–6.27

0.033

MIA score^a

 0

 2

1.17

0.45–3.05

0.742

2.14

0.77–5.96

0.147

 4

2.51

0.79–8.03

0.121

1.86

0.39–8.73

0.436

 6

5.23

1.76–15.53

0.003

2.93

0.90–9.54

0.075

 8

7.53

2.28–24.85

0.001

3.11

0.73–13.29

0.125

 10

32.96

7.30–148.94

<0.001

34.29

8.29–141.84

<0.001

Group by MIA score^a

 0

 2–4

1.33

0.56–3.16

0.517

2.05

0.79–5.35

0.142

 6

5.28

1.78–15.68

0.003

3.06

0.94–9.99

0.063

 8–10

11.18

4.12–30.33

<0.001

6.12

1.84–20.32

0.003